Atopic dermatitis is a skin disease that affects persons with sensitive skin. It is one of the most common diseases afflicting the skin; it is severe in nature. Atopic dermatitis is accompanied by hay fever, allergic asthma, anaphylaxis, food allergies, and its occurrence is more widespread among infants.
Market Research Future (MRFR) has published a comprehensive report on the global atopic dermatitis market, which covers valuable market insights derived from a thorough analysis of the pertinent trend and factors affecting the market over the forecast period of 2017-2023. MRFR’s analysis has predicted a CAGR of 8.2% during the forecast period.
Allergan Plc. (Republic of Ireland), Galderma S.A. (Switzerland), Bristol-Myers Squibb (U.S.), Sanofi S.A. (France), Pfizer Inc. (U.S.), Anacor Pharmaceuticals Inc. (U.S.), Meda Pharmaceuticals (U.S.), Novartis International AG (Switzerland), Regeneron Pharmaceuticals, Inc. (U.S.), Astellas Pharma Inc. (Japan), and Valeant Pharmaceuticals International, Inc (Canada) are the key players in the global atopic dermatitis market.
Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1610
The prevalence of atopic has increased in recent years, which necessitates diagnosis and treatment. Growing awareness regarding the disease has led to an increase in detection of the disease as more patients opt for diagnosis. The severe nature of the disease misguides the immune system and may ultimately give rise to other chronic diseases. Increasing awareness, along with heightened expenditure on healthcare, has boosted the growth of the atopic dermatitis market. Moreover, with the disease becoming widely prevalent, various health insurance companies are providing favorable reimbursement schemes for the disease, which has further increased the diagnosis and treatment of the disease. Furthermore, the governments in multiple countries are proving health schemes which provide treatment and medications at affordable price. Additionally, advancement in treatment procedures has also fostered the growth of the atopic dermatitis market.
Conversely, the growth of the market might be hampered by the lack of favorable reimbursement policies in developing countries and high costs aligned with treatment.
Segmentation
The global Atopic Dermatitis Market has been segmented based on type, application, and end user.
By type, the atopic dermatitis market has been segmented into hormone, Erythropoietin, Monoclonal antibodies, Interferon, Calcitonin, and others.
By application, the atopic dermatitis market has been segmented into cancer, blood disorders, chronic diseases, infectious diseases, and others.
By end user, the atopic dermatitis market has been segmented into hospitals, clinics, and research centers.
Regional Analysis
Region-wise, the atopic dermatitis market has been segmented into the Americas, Europe, the Middle East & Africa (MEA), and Asia Pacific (APAC).
The Americas is leading the global atopic dermatitis market on account of increasing patient pool suffering the disease and high healthcare spending. A substantial number of demographic are deficient in protein filaggrin, which leads to the increasing prevalence of atopic dermatitis in the region. Government grants for R&D to develop treatment and drugs for the disease along with the clustering of major market players in the region is supporting the growth of the market. Other factors boosting the market growth include high usage of skin irritants such as soaps, detergents, perfumes, cosmetics.
Europe accounts for the second largest portion of the global atopic dermatitis market. High government support for R&D activities, especially in Germany and France is driving the growth of the market in Europe.
The APAC atopic dermatitis market is estimated to register the highest CAGR over the forecast period. Expanding patient population suffering from atopic dermatitis who are outlaying massive expenditure on healthcare due to increasing disposable income in the region is fueling the growth of the market. Furthermore, countries such as South Korea and India are trying to make advanced treatment options available to the mass which would contribute to the growth of the market over the forecast period.
Get More Information on Atopic Dermatitis Market Research Report- Global Forecast till 2023 @ https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610
List of Tables
Table 1 Atopic Dermatitis Industry Synopsis, 2017-2023
Table 2 Global Atopic Dermatitis Market Estimates and Forecast, 2017-2023, (Usd Million)
Table 3 Global Atopic Dermatitis Market by Region, 2017-2023, (Usd Million)
Table 4 Global Atopic Dermatitis Market by Types, 2017-2023, (Usd Million)
Table 5 Global Atopic Dermatitis Market by Application, 2017-2023, (Usd Million)
Table 6 Global Atopic Dermatitis Market by End Users, 2017-2023, (Usd Million)
Table 7 North America Atopic Dermatitis Market by Types, 2017-2023, (Usd Million)
Table 8 North America Atopic Dermatitis Market by Application, 2017-2023, (Usd Million)
Table 9 North America Atopic Dermatitis Market by End Users, 2017-2023, (Usd Million)
Table 10 Us Atopic Dermatitis Market by Types, 2017-2023, (Usd Million)
Continued………
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Global Atopic Dermatitis Market
Figure 3 Segmentation Market Dynamics for Atopic Dermatitis Market
Figure 4 Global Atopic Dermatitis Market Share, by Type 2016
Figure 5 Global Atopic Dermatitis Market Share, by Application 2016
Figure 6 Global Atopic Dermatitis Market Share, by End Users, 2016
Figure 7 Global Atopic Dermatitis Market Share, by Region, 2016
Figure 8 America Atopic Dermatitis Market Share, by Country, 2016
Figure 9 Europe Atopic Dermatitis Market Share, by Country, 2016
Figure 10 Asia Pacific Atopic Dermatitis Market Share, by Country, 2016
Continued……..
Ask for your specific company profile and country level customization on reports.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610